Skip to main content

Biobanking Market is Gaining Gradually at a Healthy CAGR of 7.6% During Forecast 2018-2023


Market Overview:
The global biobanking market is undergoing massive evolution in the form of technological innovations in genetic tools, which help elevate the demand for high-quality biospecimens used for enhancing cancer research. Citing a reference, Northwell Health had partnered with Indivumed in January 2017 for creating a cancer research biobank. In addition, the current developments in information technology as well as automation solutions have enhanced the efficiency of the biobanking services. For instance, with the launch of fully automated programmed freezers as well as refrigerators, the temperature monitoring in biobanks has become far more efficient than before.
A new report on the global Biobanking Market Trends published by Market Research Future (MRFR), concludes that this market can view gains at 7.6% CAGR  between 2018 and 2023.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5967
The data received from samples can often be used for several purposes. Rising demand for biosamples, tumor cells for clinical trials and others can provide substantial traction to the market. The increasing rate of investment from both the private and public sector can trigger impressive growth.
However, the biobanking market is also getting muddled by a lot of ethical questions owing to which the expected rise could drop a little during the forecast period.
Key Players:
·         Becton Dickinson & Company
·         Brooks Automation Inc
·         Chart Industries Inc
·         Greiner Holding AG
·         Hamilton Company
·         Merck KGaA
·         Panasonic Healthcare Holdings Co
·         Promega Corporation
·         Qiagen N.V.
·         Tecan Trading AG
·         Thermo Fisher Scientific Inc
·         VWR Corporation
Market Segmentation:
·         The global biobanking market segmentation encompasses application, end-use, product & services, sample type, and storage type. MRFR’s take on the market marks various facets of the market in-depth.
·         The application-based segmentation of this market covers clinical research, life science research, regenerative medicine, and others.
·         Based on end-use, the market has been segmented into diagnostic laboratory, hospitals, research centers, and others.
·         Based on the sample type, the market has been segmented into biological fluids, blood products, cell lines, human tissues, nucleic acids, and others.
·         Regarding storage type, the market has been segmented into automated storage and manual storage.
·         The products & services segment has been segmented into consumables, equipment, services, and software. The consumables segment has been sub-segmented into analysis consumables, collection consumables, processing consumables, and storage consumables. The services segment has been sub-segmented into processing services, storage services, supply services, and transport services.
Regional Segmentation:
Region-specific analysis of the biobanking market leads to the inclusion of the Americas, Europe, Asia Pacific (MEA), and the Middle East & Africa (MEA). The regional market has two regions, North America and South America. North America’s entry depends mostly on the prospect associated mainly on the superlative infrastructure. The U.S. is one chief contributor of the region where growth in the number of hospital-based biobanks is driving the demand forward. Canada is expected to amass the maximum CAGR during the forecast period. The market is getting driven by cost-effective aspects.
The European biobanking market is relying mostly on the investments granted for research and development from various organizations and governments. It is getting further aid from advanced technologies.  Germany and the U.K. provide the maximum coverage for the regional market growth the market and is receiving substantial backup from the healthcare sector.
Asia Pacific’s growth is expected to be the fastest as the technology is getting increasingly adopted in the healthcare sector to meet the demands generated by chronic diseases. Early diagnosis and treatment are necessary in such cases which are driving the business growth ahead.
The MEA biobanking market can record a steady rise owing to the poor infrastructure. Researches are mostly taking place in the Middle East part where countries are investing money to get better healthcare benefits. In the African region, awareness about biobank facilities is fueling the growth of the market.The Matrix Gemini Biobank Management System from Autoscribe Informatics is now offering users, greater versatility by including environmental monitoring and equipment calibration. The new system also offers maintenance monitoring capabilities.

Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Medical Devices and Accessories Market is Growing at a Healthy CAGR of 6.53% During Forecast to 2023

Market Insights: Medical devices and accessories refer to any apparatus, machine, instrument used for the treatment of disease and illness through monitoring, diagnosis, and treatment. Growing occurrences of chronic diseases and diabetes, geriatric population, rising cases of surgical cases, healthcare expenditure, and technological advancements for superior medical infrastructures, and constant investments by industry giants are some of the pointers that might help the global medical device and accessories market to flourish during the forecast period. Market Research Future stated that the global Covid 19 Analysis on Medical Devices and Accessories Market Growth is estimated to register a CAGR of 6.53%, reaching the valuation of USD 133,835.9 , during the forecast period, 2014-2023 . Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5466 Other additional factors influencing the growth of the global market include mergers and collaboration led by the...
Post a Comment
Read more

BRIC Diabetes Treatment and Prevention Market is Supposed to Gain at a Fruitful CAGR of 11.52% During Forecast to 2023

Market Highlights Diabetes drugs are the drugs which are administered for the treatment of different types of Diabetes. The prevalence of diabetes is on the rise due to increased life expectancy, changing lifestyles, and the rising incidence of obesity. Diabetes can be kept in control with the help of medication, exercise and controlled diet.  Diabetes Prevention Industry in BRICS is expected to reach  USD 9.45 billion  by 2023 at a CAGR of 11.52%   during forecast period 2017 to 2023. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1323 Test the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Diabetes treatment and prevention market Research Report –BRICS Forecast to 2023.” BRICS diabetes treatment and prevention market players: Key players in diabetes treatment...
Post a Comment
Read more

Fluoroscopy and Mobile C-Arms Market is Substantially Gaining at a CAGR of 4.58% During Forecast to 2023

Market Overview: The increasing prevalence of chronic diseases is expected to have a significant impact on the fluoroscopy and mobile c-arms market. The market is also being encouraged by the massive geriatric population present globally. The increased pace of development in the healthcare sector is also anticipated to motivate the fluoroscopy and mobile c-arms market in the coming forecast period. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/7717 Fluoroscopy can be defined as an imaging technique, which uses X-Ray technology for taking real-time images of the body. It allows the physicians to visualize muscles, organs, and bones, which further helps them to make crucial decisions during surgery. The global Fluoroscopy And Mobile C-Arms Market Growth as per a report by Market Research Future (MRFR) is touted to register a CAGR of 4.58%, surpassing a valuation of USD 2,951.4 million during the forecast period. Competitive Dashboard: Canon Medical ...
Post a Comment
Read more